PAPER Mei X, Ezan P, Giaume C, Koulakoff A
SEARCH RESULTS
330913 RESULTS
PAPER Zabel C, Nguyen HP, Hin SC, Hartl D, Mao L, Klose J
Proteasome and oxidative phoshorylation changes may explain why aging is a risk factor for neurodegenerative disorders.
J Proteomics. 2010 Oct 10;73(11):2230-8. PubMed: 20813214PAPER Schneider LS, Kennedy RE, Cutter GR,
Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials.
Alzheimers Dement. 2010 Sep;6(5):367-77. PubMed: 20813339PAPER Kobayashi Z, Tsuchiya K, Arai T, Yokota O, Yoshida M, Shimomura Y, Kondo H, Haga C, Asaoka T, Onaya M, Ishizu H, Akiyama H, Mizusawa H
Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss.
J Neurol Sci. 2010 Nov 15;298(1-2):70-7. PubMed: 20810131PAPER Clark J, Clore EL, Zheng K, Adame A, Masliah E, Simon DK
Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice.
PLoS One. 2010;5(8):e12333. PubMed: 20808797PAPER Takadera T, Koriyama Y, Kimura T, Kato S
5-S-GAD attenuates Fe²+-induced lipid peroxidation and cell death in a neuronal cell model.
Neurotox Res. 2011 Jul;20(1):26-31. PubMed: 20809179PAPER Bartels AL, Leenders KL
Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.
Curr Neuropharmacol. 2010 Mar;8(1):62-8. PubMed: 20808546PAPER Braunstein KE, Eschbach J, Ròna-Vörös K, Soylu R, Mikrouli E, Larmet Y, René F, Gonzalez de Aguilar JL, Loeffler JP, Müller HP, Bucher S, Kaulisch T, Niessen HG, Tillmanns J, Fischer K, Schwalenstöcker B, Kassubek J, Pichler B, Stiller D, Petersen A, Ludolph AC, Dupuis L
A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons.
Hum Mol Genet. 2010 Nov 15;19(22):4385-98. PubMed: 20807776PAPER Horowitz MP, Greenamyre JT
Gene-environment interactions in Parkinson's disease: the importance of animal modeling.
Clin Pharmacol Ther. 2010 Oct;88(4):467-74. PubMed: 20811350PAPER Wagner B, Sibilia M
Methods to study MAP kinase signalling in the central nervous system.
Methods Mol Biol. 2010;661:481-95. PubMed: 20812003PAPER Ezzi SA, Larivière R, Urushitani M, Julien JP
Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS.
J Neurochem. 2010 Dec;115(5):1102-11. PubMed: 20807312PAPER Fedele V, Roybon L, Nordström U, Li JY, Brundin P
Neurogenesis in the R6/2 mouse model of Huntington's disease is impaired at the level of NeuroD1.
Neuroscience. 2011 Jan 26;173:76-81. PubMed: 20807561PAPER Kuhlman SJ, Lu J, Lazarus MS, Huang ZJ
Maturation of GABAergic inhibition promotes strengthening of temporally coherent inputs among convergent pathways.
PLoS Comput Biol. 2010 Jun;6(6):e1000797. PubMed: 20532211PAPER Yang Z, Klionsky DJ
Eaten alive: a history of macroautophagy.
Nat Cell Biol. 2010 Sep;12(9):814-22. PubMed: 20811353PAPER Papaleo E, Invernizzi G
Conformational diseases: structural studies of aggregation of polyglutamine proteins.
Curr Comput Aided Drug Des. 2011 Mar;7(1):23-43. PubMed: 20807186Current Filters
No filters selected